Lupus nephritis
Not recruitingStudy on Anifrolumab for Adults with Active Lupus Nephritis
- Disease:Lupus nephritis
- Substances:Anifrolumab
Italy- Participants:18–64 years · 65+ years
- Substances:Anifrolumab
- Sponsor:AstraZeneca AB
Rare diseases
Investigational molecules
Locations
Back to Italy191 clinical trials in Ferrara, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on heart failure prevention and treatment of cardiovascular conditions, including trials testing new therapies for high-risk patients.
Advanced clinical investigations exploring precision medicine approaches and preventive interventions.
Comprehensive research into various cancer types, including pleural mesothelioma and breast cancer, evaluating novel treatment combinations and therapeutic approaches.
Focus on improving patient outcomes through targeted therapies and immunotherapy protocols.
Studies examining treatments for psoriatic arthritis and other autoimmune conditions, investigating innovative biological therapies.
Investigation of novel therapeutic approaches for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.